COAG · Hemab Therapeutics Holdings, Inc. · Investor Relations
$38.56
-0.59 (-1.51%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.83B
Shares
46.73M
Volume · Nov 19
59.54K
Avg daily vol (3M)
496.12K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-12-01 20:00 UTC | 9th Annual Evercore Healthcare Conference | Conference |
| 2026-12-01 20:00 UTC | Evercore Healthcare Conference | Conference |
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-17 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-11-10 | Hemab Therapeutics Third Quarter 2026 Financial Results and Corporate Update | Earnings call |
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
Source: https://ir.hemab.com/
Key facts
CIK
2114044
CUSIP
423494103
13F (30d)
89 filings
88 filers
Visit website
Investor relations